Standalone Meeting Slides
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Biomarker developments: predicting the future in patients with ILD
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Recent advances in CTD-ILD: the perspective of a rheumatologist
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: New targets for the treatment of ILD
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Diagnostic guidelines: new data that must be taken aboard
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Examining ILAs and their significance to development of ILD
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Demystifying cHP: an imaging perspective
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Debate: Is diagnostic certainty a prerequisite for treatment? Pro
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Debate: Is diagnostic certainty a prerequisite for treatment? Con
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Debate – Do IPAF criteria need refinement? Pro
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Debate – Do IPAF criteria need refinement? Con
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Keynote speech – Lung transplant in IPF: lessons learned from Sweden
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Antifibrotics in non-IPF diseases – unclassifiable ILD
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Antifibrotics in non-IPF diseases – non-IPF lung fibrosis (RELIEF)
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Antifibrotics in non-IPF diseases – SSc-ILD (SENSCIS)
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Antifibrotics in non-IPF diseases – PF-ILD (INBUILD)
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Acute exacerbations in ILD: the past, present and future
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: Home monitoring: power to the patient?
-
PDFNov 27, 2019 | Idiopathic Pulmonary Fibrosis AIR 2019 Idiopathic Pulmonary Fibrosis
AIR 2019: New diagnostic tools